BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
274 hedge funds and large institutions have $5.27B invested in bluebird bio in 2019 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 92 increasing their positions, 70 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more funds holding
Funds holding: 241 → 274 (+33)
0.54% less ownership
Funds ownership: 8.93% → 8.39% (-0.54%)
10% less capital invested
Capital invested by funds: $5.87B → $5.27B (-$597M)
Holders
274
Holding in Top 10
3
Calls
$103M
Puts
$71.3M
Top Buyers
| 1 | +$87.4M | |
| 2 | +$50.5M | |
| 3 | +$48.3M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$42M |
| 5 |
Goldman Sachs
New York
|
+$31.5M |
Top Sellers
| 1 | -$346M | |
| 2 | -$242M | |
| 3 | -$148M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$79.3M |
| 5 |
CII
Capital International Inc
Los Angeles,
California
|
-$31.2M |